vs
ENERPAC TOOL GROUP CORP（EPAC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是ENERPAC TOOL GROUP CORP的1.4倍（$197.9M vs $144.2M），ENERPAC TOOL GROUP CORP净利率更高（13.3% vs 6.7%，领先6.6%），REPLIGEN CORP同比增速更快（13.6% vs -0.7%），REPLIGEN CORP自由现金流更多（$17.6M vs $13.3M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 2.1%）
恩派克工具集团前身为Actuant公司，成立于1910年，总部位于美国威斯康星州梅诺莫尼福尔斯，是一家历史悠久的工业工具企业，其普通股在纽约证券交易所上市，股票代码为EPAC。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
EPAC vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$144.2M
营收增速更快
RGEN
高出14.3%
-0.7%
净利率更高
EPAC
高出6.6%
6.7%
自由现金流更多
RGEN
多$4.3M
$13.3M
两年增速更快
RGEN
近两年复合增速
2.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $144.2M | $197.9M |
| 净利润 | $19.1M | $13.3M |
| 毛利率 | 50.7% | 52.5% |
| 营业利润率 | 19.8% | 9.0% |
| 净利率 | 13.3% | 6.7% |
| 营收同比 | -0.7% | 13.6% |
| 净利润同比 | -11.9% | 143.9% |
| 每股收益（稀释后） | $0.36 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPACRGEN
| Q4 25 | $144.2M | $197.9M | ||
| Q3 25 | $167.5M | $188.8M | ||
| Q2 25 | $158.7M | $182.4M | ||
| Q1 25 | $145.5M | $169.2M | ||
| Q4 24 | $145.2M | $174.1M | ||
| Q3 24 | $158.7M | $154.9M | ||
| Q2 24 | $150.4M | $154.1M | ||
| Q1 24 | $138.4M | $151.3M |
净利润EPACRGEN
| Q4 25 | $19.1M | $13.3M | ||
| Q3 25 | $28.1M | $14.9M | ||
| Q2 25 | $22.0M | $14.9M | ||
| Q1 25 | $20.9M | $5.8M | ||
| Q4 24 | $21.7M | $-30.3M | ||
| Q3 24 | $24.4M | $-654.0K | ||
| Q2 24 | $25.8M | $3.3M | ||
| Q1 24 | $17.8M | $2.1M |
毛利率EPACRGEN
| Q4 25 | 50.7% | 52.5% | ||
| Q3 25 | 50.1% | 53.2% | ||
| Q2 25 | 50.4% | 50.0% | ||
| Q1 25 | 50.5% | 53.6% | ||
| Q4 24 | 51.4% | 26.1% | ||
| Q3 24 | 48.8% | 50.0% | ||
| Q2 24 | 51.8% | 49.8% | ||
| Q1 24 | 51.6% | 49.5% |
营业利润率EPACRGEN
| Q4 25 | 19.8% | 9.0% | ||
| Q3 25 | 23.8% | 8.9% | ||
| Q2 25 | 20.0% | 7.6% | ||
| Q1 25 | 21.2% | 3.9% | ||
| Q4 24 | 21.4% | -17.7% | ||
| Q3 24 | 18.9% | -5.1% | ||
| Q2 24 | 22.2% | 1.0% | ||
| Q1 24 | 21.3% | 1.3% |
净利率EPACRGEN
| Q4 25 | 13.3% | 6.7% | ||
| Q3 25 | 16.8% | 7.9% | ||
| Q2 25 | 13.9% | 8.2% | ||
| Q1 25 | 14.4% | 3.4% | ||
| Q4 24 | 15.0% | -17.4% | ||
| Q3 24 | 15.4% | -0.4% | ||
| Q2 24 | 17.1% | 2.2% | ||
| Q1 24 | 12.9% | 1.4% |
每股收益（稀释后）EPACRGEN
| Q4 25 | $0.36 | $0.24 | ||
| Q3 25 | $0.51 | $0.26 | ||
| Q2 25 | $0.41 | $0.26 | ||
| Q1 25 | $0.38 | $0.10 | ||
| Q4 24 | $0.40 | $-0.55 | ||
| Q3 24 | $0.44 | $-0.01 | ||
| Q2 24 | $0.47 | $0.06 | ||
| Q1 24 | $0.33 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $139.0M | $767.6M |
| 总债务越低越好 | $188.8M | $542.2M |
| 股东权益账面价值 | $431.1M | $2.1B |
| 总资产 | $818.1M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资EPACRGEN
| Q4 25 | $139.0M | $767.6M | ||
| Q3 25 | $151.6M | $748.7M | ||
| Q2 25 | $140.5M | $708.9M | ||
| Q1 25 | $119.5M | $697.2M | ||
| Q4 24 | $130.7M | $757.4M | ||
| Q3 24 | $167.1M | $784.0M | ||
| Q2 24 | $132.4M | $809.1M | ||
| Q1 24 | $153.7M | $780.6M |
总债务EPACRGEN
| Q4 25 | $188.8M | $542.2M | ||
| Q3 25 | $190.0M | $537.9M | ||
| Q2 25 | $191.3M | — | ||
| Q1 25 | $192.5M | — | ||
| Q4 24 | $193.8M | $525.6M | ||
| Q3 24 | $195.0M | — | ||
| Q2 24 | $196.3M | — | ||
| Q1 24 | $245.5M | — |
股东权益EPACRGEN
| Q4 25 | $431.1M | $2.1B | ||
| Q3 25 | $433.7M | $2.1B | ||
| Q2 25 | $438.2M | $2.1B | ||
| Q1 25 | $406.0M | $2.0B | ||
| Q4 24 | $398.0M | $2.0B | ||
| Q3 24 | $392.0M | $2.0B | ||
| Q2 24 | $365.8M | $2.0B | ||
| Q1 24 | $336.9M | $2.0B |
总资产EPACRGEN
| Q4 25 | $818.1M | $2.9B | ||
| Q3 25 | $827.9M | $2.9B | ||
| Q2 25 | $828.1M | $2.9B | ||
| Q1 25 | $776.6M | $2.9B | ||
| Q4 24 | $775.4M | $2.8B | ||
| Q3 24 | $777.3M | $2.8B | ||
| Q2 24 | $749.5M | $2.9B | ||
| Q1 24 | $769.3M | $2.8B |
负债/权益比EPACRGEN
| Q4 25 | 0.44× | 0.26× | ||
| Q3 25 | 0.44× | 0.26× | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.49× | 0.27× | ||
| Q3 24 | 0.50× | — | ||
| Q2 24 | 0.54× | — | ||
| Q1 24 | 0.73× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $13.3M | $17.6M |
| 自由现金流率自由现金流/营收 | 9.2% | 8.9% |
| 资本支出强度资本支出/营收 | 1.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.84× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $102.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流EPACRGEN
| Q4 25 | $16.0M | $25.7M | ||
| Q3 25 | $55.3M | $48.1M | ||
| Q2 25 | $39.9M | $28.6M | ||
| Q1 25 | $7.5M | $15.0M | ||
| Q4 24 | $8.6M | $39.2M | ||
| Q3 24 | $44.4M | $49.3M | ||
| Q2 24 | $30.3M | $42.2M | ||
| Q1 24 | $13.3M | $44.7M |
自由现金流EPACRGEN
| Q4 25 | $13.3M | $17.6M | ||
| Q3 25 | $52.3M | $43.4M | ||
| Q2 25 | $35.1M | $21.5M | ||
| Q1 25 | $1.8M | $11.4M | ||
| Q4 24 | $2.8M | $33.6M | ||
| Q3 24 | $37.9M | $42.3M | ||
| Q2 24 | $28.5M | $37.4M | ||
| Q1 24 | $11.7M | $36.4M |
自由现金流率EPACRGEN
| Q4 25 | 9.2% | 8.9% | ||
| Q3 25 | 31.2% | 23.0% | ||
| Q2 25 | 22.1% | 11.8% | ||
| Q1 25 | 1.2% | 6.8% | ||
| Q4 24 | 1.9% | 19.3% | ||
| Q3 24 | 23.9% | 27.3% | ||
| Q2 24 | 18.9% | 24.3% | ||
| Q1 24 | 8.5% | 24.0% |
资本支出强度EPACRGEN
| Q4 25 | 1.9% | 4.1% | ||
| Q3 25 | 1.8% | 2.5% | ||
| Q2 25 | 3.1% | 3.9% | ||
| Q1 25 | 3.9% | 2.1% | ||
| Q4 24 | 4.0% | 3.2% | ||
| Q3 24 | 4.1% | 4.5% | ||
| Q2 24 | 1.2% | 3.1% | ||
| Q1 24 | 1.1% | 5.5% |
现金转化率EPACRGEN
| Q4 25 | 0.84× | 1.93× | ||
| Q3 25 | 1.97× | 3.23× | ||
| Q2 25 | 1.81× | 1.92× | ||
| Q1 25 | 0.36× | 2.57× | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | 1.18× | 12.70× | ||
| Q1 24 | 0.75× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EPAC
| Transferred At Point In Time | $126.0M | 87% |
| Other | $12.1M | 8% |
| Other Operating Segment | $6.1M | 4% |
RGEN
暂无分部数据
